Related Experiment Video
Updated: Jan 22, 2026

Removal and Replacement of Endogenous Ligands from Lipid-Bound Proteins and Allergens
Published on: February 24, 2021
Proresolving Lipid Mediators: Endogenous Modulators of Oxidative Stress
Alessandro Leuti1,2, Mauro Maccarrone1,2, Valerio Chiurchiù1,2
1Department of Medicine, Campus Bio-Medico University of Rome, Via Alvaro del Portillo 21, 00128 Rome, Italy.
Specialized proresolving mediators (SPMs) resolve inflammation by regulating reactive species. These lipids offer therapeutic potential for oxidative stress-related chronic diseases.
Area of Science:
- Lipid mediators
- Inflammation resolution
- Oxidative stress
Background:
- Specialized proresolving mediators (SPMs) are endogenous lipids derived from essential fatty acids.
- SPMs orchestrate the resolution of inflammation and tissue homeostasis.
- Oxidative stress, an imbalance of reactive oxygen and nitrogen species (ROS/RNS), contributes to chronic inflammatory diseases.
Purpose of the Study:
- To explore the effects of SPMs on reactive species production.
- To elucidate mechanisms by which SPMs modulate oxidative stress pathways.
- To summarize the role of SPMs in oxidative stress-mediated disorders.
Main Methods:
- Literature review on SPMs and oxidative stress.
- Analysis of molecular signaling pathways affected by SPMs.
- Investigation of SPM-induced antioxidant system expression.
Main Results:
- SPMs modulate the production of reactive oxygen and nitrogen species.
- SPMs inhibit oxidative stress-activated signaling and induce antioxidant systems.
- SPM's anti-inflammatory and proresolving properties are linked to their antioxidant role.
Conclusions:
- SPMs possess significant antioxidant functions.
- SPMs can be therapeutically exploited for diseases involving ROS/RNS imbalance.
- SPMs represent a promising therapeutic strategy for chronic inflammatory conditions.
Related Concept Videos
Oxidation Numbers
What are Lipids?
Responses to Heat and Cold Stress
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Lipid Digestion
Receptor-mediated Endocytosis

